Ryan Preblick
Chief Financial Officer · 1 filing · Latest: Mar 14, 2026
Indivior Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|
INDV | Ryan Preblick | Chief Financial Officer | Mar 14, 2026 | Tax Withholding | $31.11 | 2,843 | $88.4K | 320,751 | |
INDV | Ryan Preblick | Chief Financial Officer | Mar 14, 2026 | Option Exercise | — | 6,302 | — | 323,594 | |